Moreover, recent studies have suggested that atypical glucose–insulin homeostasis is linked to various depression severity indicators and could be a neurohormonal mediator of certain depression symptoms, such as neurocognitive impairments, and disorders that are comorbid with depression, such as cardiovascular disease [4,5,16]. This evidence concerns the gene INS and major depressive disorder.